These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24403223)

  • 41. Device specificity of vascular healing following implantation of bioresorbable vascular scaffolds and bioabsorbable polymer metallic drug-eluting stents in human coronary arteries: the ESTROFA OCT BVS vs. BP-DES study.
    de la Torre Hernandez JM; Gonzalo N; Otaegui I; Rumoroso JR; Gutiérrez H; Alfonso F; Marti G; Serrador-Frutos AM; Brugaletta S; Gomez Menchero A; Garcia Camarero T; Biagioni C; Escaned J
    EuroIntervention; 2018 Dec; 14(12):e1295-e1303. PubMed ID: 29901443
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vascular response to everolimus- and biolimus-eluting coronary stents versus everolimus-eluting bioresorbable scaffolds--an optical coherence tomography substudy of the EVERBIO II trial.
    Kallinikou Z; Arroyo D; Togni M; Lehman S; Corpataux N; Cook M; Müller O; Baeriswyl G; Stauffer JC; Goy JJ; Puricel SG; Cook S
    Swiss Med Wkly; 2016; 146():w14274. PubMed ID: 26766027
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differences in neointimal thickness between the adluminal and the abluminal sides of malapposed and side-branch struts in a polylactide bioresorbable scaffold: evidence in vivo about the abluminal healing process.
    Gutiérrez-Chico JL; Gijsen F; Regar E; Wentzel J; de Bruyne B; Thuesen L; Ormiston J; McClean DR; Windecker S; Chevalier B; Dudek D; Whitbourn R; Brugaletta S; Onuma Y; Serruys PW
    JACC Cardiovasc Interv; 2012 Apr; 5(4):428-35. PubMed ID: 22516401
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bioresorbable everolimus-eluting vascular scaffold for the treatment of chronic total occlusions: CTO-ABSORB pilot study.
    Vaquerizo B; Barros A; Pujadas S; Bajo E; Estrada D; Miranda-Guardiola F; Rigla J; Jiménez M; Cinca J; Serra A
    EuroIntervention; 2015 Sep; 11(5):555-63. PubMed ID: 25499833
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of early clinical outcomes between ABSORB bioresorbable vascular scaffold and everolimus-eluting stent implantation in a real-world population.
    Costopoulos C; Latib A; Naganuma T; Miyazaki T; Sato K; Figini F; Sticchi A; Carlino M; Chieffo A; Montorfano M; Colombo A
    Catheter Cardiovasc Interv; 2015 Jan; 85(1):E10-5. PubMed ID: 24909303
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stent strut thickness and acute vessel injury during percutaneous coronary interventions: an optical coherence tomography randomized clinical trial.
    Vilchez-Tschischke JP; Salazar C; Gil-Romero J; Mori R; Nuñez-Gil I; Quirós A; Nombela L; Del Trigo M; Jimenez-Quevedo P; Salinas P; Escaned J; Macaya C; Gonzalo N
    Coron Artery Dis; 2021 Aug; 32(5):382-390. PubMed ID: 32826450
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents.
    Sorrentino S; Giustino G; Mehran R; Kini AS; Sharma SK; Faggioni M; Farhan S; Vogel B; Indolfi C; Dangas GD
    J Am Coll Cardiol; 2017 Jun; 69(25):3055-3066. PubMed ID: 28412389
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The relationship between post-stent strut apposition and follow-up strut coverage assessed by a contour plot optical coherence tomography analysis.
    Kim JS; Ha J; Kim BK; Shin DH; Ko YG; Choi D; Jang Y; Hong MK
    JACC Cardiovasc Interv; 2014 Jun; 7(6):641-51. PubMed ID: 24835329
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Classification of mechanisms of strut malapposition after angiographically optimized stent implantation: An optical coherence tomography study.
    Agrawal M; Hakeem A; Ahmed Z; Uretsky BF
    Catheter Cardiovasc Interv; 2017 Aug; 90(2):225-232. PubMed ID: 28805036
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Minimal Acute Recoil Following Bioresorbable Scaffold Implantation in Fibrocalcific Lesion Detected by Optical Frequency-Domain Imaging.
    Kawamoto H; Ruparelia N; Tanaka A; Latib A; Colombo A
    J Invasive Cardiol; 2016 Mar; 28(3):E34-6. PubMed ID: 26945257
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Re-endothelialisation after Synergy stent and Absorb bioresorbable vascular scaffold implantation in acute myocardial infarction: COVER-AMI study.
    Lhermusier T; Ohayon P; Boudou N; Bouisset F; Campelo-Parada F; Roncalli J; Elbaz M; Carrié D
    Trials; 2019 Apr; 20(1):210. PubMed ID: 30975219
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of Stent Expansion Guided by Optical Coherence Tomography Versus Intravascular Ultrasound: The ILUMIEN II Study (Observational Study of Optical Coherence Tomography [OCT] in Patients Undergoing Fractional Flow Reserve [FFR] and Percutaneous Coronary Intervention).
    Maehara A; Ben-Yehuda O; Ali Z; Wijns W; Bezerra HG; Shite J; Généreux P; Nichols M; Jenkins P; Witzenbichler B; Mintz GS; Stone GW
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1704-14. PubMed ID: 26585621
    [TBL] [Abstract][Full Text] [Related]  

  • 53. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds.
    Puricel S; Arroyo D; Corpataux N; Baeriswyl G; Lehmann S; Kallinikou Z; Muller O; Allard L; Stauffer JC; Togni M; Goy JJ; Cook S
    J Am Coll Cardiol; 2015 Mar; 65(8):791-801. PubMed ID: 25720622
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bioresorbable Vascular Scaffold With Optimized Implantation Technique: Long-Term Outcomes From a Single-Center Experience.
    Albani S; Giannini F; Mitomo S; Fabris E; Mangieri A; Ponticelli F; Khokhar AA; Toselli M; Latib A; Colombo A
    J Invasive Cardiol; 2021 Feb; 33(2):E115-E122. PubMed ID: 33443487
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optical Coherence Tomography for Coronary Bioresorbable Vascular Scaffold Implantation: A Randomized Controlled Trial.
    Lee SY; Kang DY; Hong SJ; Ahn JM; Ahn CM; Park DW; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Park SJ; Hong MK
    Circ Cardiovasc Interv; 2020 Jan; 13(1):e008383. PubMed ID: 32525410
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanisms of Very Late Bioresorbable Scaffold Thrombosis: The INVEST Registry.
    Yamaji K; Ueki Y; Souteyrand G; Daemen J; Wiebe J; Nef H; Adriaenssens T; Loh JP; Lattuca B; Wykrzykowska JJ; Gomez-Lara J; Timmers L; Motreff P; Hoppmann P; Abdel-Wahab M; Byrne RA; Meincke F; Boeder N; Honton B; O'Sullivan CJ; Ielasi A; Delarche N; Christ G; Lee JKT; Lee M; Amabile N; Karagiannis A; Windecker S; Räber L
    J Am Coll Cardiol; 2017 Nov; 70(19):2330-2344. PubMed ID: 29096803
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of the endothelial shear stress patterns on neointimal proliferation following drug-eluting bioresorbable vascular scaffold implantation: an optical coherence tomography study.
    Bourantas CV; Papafaklis MI; Kotsia A; Farooq V; Muramatsu T; Gomez-Lara J; Zhang YJ; Iqbal J; Kalatzis FG; Naka KK; Fotiadis DI; Dorange C; Wang J; Rapoza R; Garcia-Garcia HM; Onuma Y; Michalis LK; Serruys PW
    JACC Cardiovasc Interv; 2014 Mar; 7(3):315-24. PubMed ID: 24529931
    [TBL] [Abstract][Full Text] [Related]  

  • 59. "Assessment of effectiveness and security in high pressure postdilatation of bioresorbable vascular scaffolds during percutaneous coronary intervention. Study in a contemporary, non-selected cohort of Spanish patients".
    Abellas-Sequeiros RA; Ocaranza-Sanchez R; Galvão Braga C; Raposeiras-Roubin S; Lopez-Otero D; Cid-Alvarez B; Souto-Castro P; Trillo-Nouche R; Gonzalez-Juanatey JR
    Int J Cardiol; 2016 Sep; 219():264-70. PubMed ID: 27343418
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mid-term clinical outcomes of ABSORB bioresorbable vascular scaffold implantation in a real-world population: A single-center experience.
    Costopoulos C; Crowson MC; Brown AJ; Braganza DM; Bennett MR; Hoole SP; West NE
    Cardiovasc Revasc Med; 2015 Dec; 16(8):461-4. PubMed ID: 26440767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.